A detailed history of Harbor Capital Advisors, Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 20,768 shares of TARS stock, worth $1.01 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
20,768
Previous 22,113 6.08%
Holding current value
$1.01 Million
Previous $1.22 Million 12.83%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 14, 2025

SELL
$41.29 - $56.94 $55,535 - $76,584
-1,345 Reduced 6.08%
20,768 $1.07 Million
Q4 2024

Jan 10, 2025

BUY
$32.27 - $55.37 $129,338 - $221,922
4,008 Added 22.14%
22,113 $1.22 Million
Q3 2024

Oct 29, 2024

BUY
$21.54 - $34.6 $142,422 - $228,775
6,612 Added 57.53%
18,105 $595,000
Q2 2024

Jul 09, 2024

SELL
$25.17 - $38.73 $3,196 - $4,918
-127 Reduced 1.09%
11,493 $312,000
Q1 2024

May 13, 2024

BUY
$19.61 - $39.22 $227,868 - $455,736
11,620 New
11,620 $422,000

Others Institutions Holding TARS

About Tarsus Pharmaceuticals, Inc.


  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.3B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.